Intravenous tPA Administration in Patients With Acute Ischemic Stroke: Edirne Experience

Asil T., Balci K., Utku U., Ir N.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, vol.28, no.3, pp.317-321, 2011 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 28 Issue: 3
  • Publication Date: 2011
  • Journal Name: JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.317-321
  • Bezmialem Vakıf University Affiliated: No

Abstract

Objective: Intravenous (IV) thrombolytic therapy is the only approved effective treatment used in patients with acute ischemic stroke. In this study, we aimed at establishing the clinical outcomes of the IV tissue plasminogen activator (tPA) therapy and the main factors affecting the success rate of the treatment.